SEC Axes Eli Lilly Bid To Duck Diversity, Abortion Reports
Eli Lilly & Co. cannot dodge a pair of shareholder proposals seeking reports on the pharmaceutical company's diversity, equity and inclusion efforts and its views on abortion, the U.S. Securities and...To view the full article, register now.
Already a subscriber? Click here to view full article